Status:
UNKNOWN
Efficacy of Expressive Writing on Quality of Life Among Breast Cancer Survivors in Oman: A Double Blind Randomized Controlled Trial
Lead Sponsor:
Sultan Qaboos University
Conditions:
Breast Cancer
Quality of Life
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Background Breast cancer is the most common cancer affecting women globally. Additionally, it is the most common cause of cancer mortality among women. Internationally, breast cancer is the most frequ...
Detailed Description
Background Breast cancer is the most common cancer affecting women globally. Additionally, it is the most common cause of cancer mortality among women. Internationally, breast cancer is the most frequ...
Eligibility Criteria
Inclusion
- Omani Women Having a breast cancer diagnosis stage, I and II
- Completing breast cancer surgery within 5 years
- Subsequently received adjuvant treatment including chemotherapy, hormonal treatment, or Radiation therapy
- Being comfortable writing and speaking in Arabic Or English
Exclusion
- Nonconsenting
- Presence of severe physical illness
- Diagnoses with severe Mental or intellectual disorder
- Advanced breast cancer
- Un able to comply with trial protocol
- Presence of another cancer diagnoses
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04843358
Start Date
January 1 2022
End Date
December 30 2024
Last Update
April 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.